Martina Bebin

University Of Alabama At Birmingham

$9,634,677

Attributed

$11,266,510

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.7M · FY2012–25

$2M$1.5M$1M$500K$0

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$8,968,808 · 3

FDA$3,263,666 · 1

By mechanism

U01$7,084,397 · 1

R01$3,263,666 · 1

P20$1,884,411 · 2

Top collaborators

Darcy Krueger3 shared

Most similar at University Of Alabama At Birmingham

Same institution · by research overlap

Upender Manne$11,389,346
Isabel C Scarinci$19,061,797
Christopher Ryan Miller$3,962,587
Alan Kenneth Percy$11,873,575
Lucio Miele$8,893,296

Others in their field

Top investigators on “Antiepileptogenic”

Kevin J. Staley · University Of Colorado Denver$9,074,444
Aristea S Galanopoulou · Yeshiva University$8,183,282
Arthur W Toga · University Of Southern California$7,490,656
Thimmasettappa Thippeswamy · Iowa State University$4,964,781
Frances E Jensen · Children'S Hospital Boston$4,467,032
Paul M Vespa · Emory University$4,300,547

Research focus

AntiepileptogenicEpilepsyElectroencephalographyInfantile SpasmsBasePharmaceutical PreparationsSeizuresCommunicationLifePreventTuberous Sclerosis Protein ComplexVigabatrinBiological MarkersClinical TrialsDiagnosisEpileptogenesisInfancyAdverse EffectsStagingAnimalsAdverse EventBehavioralCognitiveAnimal Model